Previous 10 |
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2019 Results Earnings Conference Call May 14, 2019, 04:30 PM ET Company Participants Erin Smith - Corporate Relations A.J. Kazimi - CEO Marty Cearnal - Chief Commercial Officer Michael Bonner - CFO Conference Call Participants And...
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q1 Non-GAAP EPS of $0.11 beats by $0.22 ; GAAP EPS of $0.00 beats by $0.22 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NASHVILLE, Tenn. , May 14, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced first quarter 2019 financial results with net revenues o...
NASHVILLE, Tenn. , May 7, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2019 financial results after the market closes on Tuesday, May 14 , 2019. A conference call and live Internet webcast will be held...
NASHVILLE, Tenn. , March 29, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, today announced that it has commenced a strategic review of its branded product portfolio, as well as its roster of international partners. The C...
Cumberland Pharmaceuticals, Inc. (CPIX) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Erin Smith – Corporate Relations A. J. Kazimi – Chief Executive Officer Marty Cearnal – Chief Commercial Officer Michael Bonner ȁ...
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q4 Non-GAAP EPS of $0.10 beats by $0.35 ; GAAP EPS of -$0.14 beats by $0.11 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NASHVILLE, Tenn. , Feb. 26, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care, today announced fourth quarter and full year 2018 financial results. N...
NASHVILLE, Tenn. , Feb. 19, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2018 financial results after the market closes on Tuesday, February 26 , 2019. A conference call and live Internet w...
News, Short Squeeze, Breakout and More Instantly...
Cumberland Pharmaceuticals Inc. Company Name:
CPIX Stock Symbol:
NASDAQ Market:
Cumberland Pharmaceuticals Inc. Website:
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , Ap...
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire 2023 highlights include expanded FDA approval and new study publications NASHVILLE, Tenn. , March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a sp...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...